Cardiovascular medicine at high altitude

Angiology

Volumn 65, Issue 6, 2014, Pages 459-472

  Whayne, Thomas F ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

acute mountain sickness; altitude physiology; chronic mountain sickness; high altitude cerebral edema; high altitude pulmonary edema; hyperbaric medicine; pulmonary hypertension

Indexed keywords

ALTITUDE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ANOREXIA; BLOOD PRESSURE; BRAIN EDEMA; CARDIOVASCULAR DISEASE; DYSPNEA; ELECTROCARDIOGRAPHY; HEADACHE; HEART RIGHT VENTRICLE HYPERTROPHY; HIGH RISK POPULATION; HUMAN; HYPERVENTILATION; HYPOVENTILATION; HYPOXIA; INSOMNIA; LUNG EDEMA; NAUSEA; OXYGEN DESATURATION; POLYCYTHEMIA; PULMONARY HYPERTENSION; REVIEW; TRAVEL; ADAPTATION; AGE; ALTITUDE SICKNESS; BIOLOGICAL MODEL; BLOOD; BLOOD CLOTTING; BRAIN; BRAIN ARTERY; CAROTID BODY; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; HYPERTENSION, PULMONARY; KIDNEY DISEASE; LESIONS AND DEFECTS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA DISEASE; RISK FACTOR; SLEEP DISORDERED BREATHING; SUDDEN CARDIAC DEATH; VASCULARIZATION;

OXYGEN;

ADAPTATION, PHYSIOLOGICAL; AGE FACTORS; ALTITUDE; ALTITUDE SICKNESS; BLOOD COAGULATION; BRAIN; CARDIOVASCULAR DISEASES; CAROTID BODY; CEREBRAL ARTERIES; DEATH, SUDDEN, CARDIAC; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE; HUMANS; HYPERTENSION, PULMONARY; KIDNEY DISEASES; MODELS, BIOLOGICAL; OBESITY; OXYGEN; RETINAL DISEASES; RISK FACTORS; SLEEP APNEA SYNDROMES;

EID: 84903525668     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713497086     Document Type: Review

References (92)

1. Rudolph G. In memory of Paul Bert (1833-1886) and the development of high altitude physiology in Switzerland. Gesnerus. 1993 ; 50 (pt 1-2). 79-95
2. Marotte H. The exposure of man to altitude when flying: from Paul Bert to today. J Soc Biol. 2006 ; 200 (3). 251-255
3. Hurtado A. Some clinical aspects of life at high altitudes. Ann Intern Med. 1960 ; 53 (2). 247-258
4. Alzamora V, Rotta A, Battilana G, et al. On the possible influence of great altitudes on the determination of certain cardiovascular anomalies. Pediatrics. 1953 ; 12 ((3:1)). 259-262
5. Chavez I, Espino Vela J, Limon R, Dorbecker N. Patent ductus arteriosus; studies on 200 cases. Arch Inst Cardiol Mex. 1953 ; 23 (6). 687-755
6. Snider GL, Maldonado D. Arterial blood gases in acutely ill patients. JAMA. 1968 ; 204 (11). 991-994
7. Snider GL.. Interpretation of the arterial oxygen and carbon dioxide partial pressures. A simplified approach for bedside use. Chest. 1973 ; 63 (5). 801-806
8. McNicol MW, Campbell EJ. Severity of respiratory failure. Arterial blood-gases in untreated patients. Lancet. 1965 ; 1 (7381). 336-338
9. Edwards C, Heath D, Harris P, Castillo Y, Kruger H, Arias-Stella J. The carotid body in animals at high altitude. J Pathol. 1971 ; 104 (4). 231-238
10. Sorensen SC, Severinghaus JW. Irreversible respiratory insensitivity to acute hypoxia in man born at high altitude. J Appl Physiol. 1968 ; 25 (3). 217-220
11. West JB. The physiologic basis of high-altitude diseases. Ann Intern Med. 2004 ; 141 (10). 789-800
12. Suarez J, Alexander JK, Houston CS. Enhanced left ventricular systolic performance at high altitude during Operation Everest II. Am J Cardiol. 1987 ; 60 (1). 137-142
13. Singh MV, Rawal SB, Tyagi AK. Body fluid status on induction, reinduction and prolonged stay at high altitude of human volunteers. Int J Biometeorol. 1990 ; 34 (2). 93-97
14. Stuber T, Scherrer U. Circulatory adaptation to long-term high altitude exposure in Aymaras and Caucasians. Prog Cardiovasc Dis. 2010 ; 52 (6). 534-539
15. Steckelberg RC, Tseng AS, Nishimura R, Ommen S, Sorajja P. Derivation of mean pulmonary artery pressure from noninvasive parameters. J Am Soc Echocardiogr. 2013 ; 26 (5). 464-468
16. Bech-Hanssen O, Karason K, Rundqvist B, Bollano E, Lindgren F, Selimovic N. Can pulmonary hypertension and increased pulmonary vascular resistance be ruled in and ruled out by echocardiography?. J Am Soc Echocardiogr. 2013 ; 26 (5). 469-478
17. Lafitte S, Pillois X, Reant P, et al. Estimation of pulmonary pressures and diagnosis of pulmonary hypertension by Doppler echocardiography: a retrospective comparison of routine echocardiography and invasive hemodynamics. J Am Soc Echocardiogr. 2013 ; 26 (5). 457-463
18. Rich JD, Shah SJ, Swamy RS, Kamp A, Rich S. Inaccuracy of Doppler echocardiographic estimates of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest. 2011 ; 139 (5). 988-993
19. Fisher MR, Forfia PR, Chamera E, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med. 2009 ; 179 (7). 615-621
20. Paterson I, Michelakis ED. The role of Doppler echocardiography in pulmonary artery hypertension: the importance of proving the obvious. Chest. 2011 ; 139 (5). 973-975
21. Honigman B, Theis MK, Koziol-McLain J, et al. Acute mountain sickness in a general tourist population at moderate altitudes. Ann Intern Med. 1993 ; 118 (8). 587-592
22. Penaloza D. Effects of high-altitude exposure on the pulmonary circulation. Rev Esp Cardiol (Engl Ed). 2012 ; 65 (12). 1075-1078
23. Houston CS, Dickinson J. Cerebral form of high-altitude illness. Lancet. 1975 ; 2 (7938). 758-761
24. Fagenholz PJ, Gutman JA, Murray AF, Noble VE, Camargo CA, Harris NS. Evidence for increased intracranial pressure in high altitude pulmonary edema. High Alt Med Biol. 2007 ; 8 (4). 331-336
25. Borgstrom L, Johannsson H, Siesjo BK. The relationship between arterial po2 and cerebral blood flow in hypoxic hypoxia. Acta Physiol Scand. 1975 ; 93 (3). 423-432
26. Harper AM, Glass HI. Effect of alterations in the arterial carbon dioxide tension on the blood flow through the cerebral cortex at normal and low arterial blood pressures. J Neurol Neurosurg Psychiatry. 1965 ; 28 (5). 449-452
27. Julian CG, Subudhi AW, Wilson MJ, Dimmen AC, Pecha T, Roach RC. Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study. J Appl Physiol. 2011 ; 111 (2). 392-399
28. Leaf DE, Goldfarb DS. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol. 2007 ; 102 (4). 1313-1322
29. Kallenberg K, Bailey DM, Christ S, et al. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab. 2007 ; 27 (5). 1064-1071
30. Bailey DM, Roukens R, Knauth M, et al. Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab. 2006 ; 26 (1). 99-111
31. Jones BE, Stokes S, McKenzie S, Nilles E, Stoddard GJ. Management of high altitude pulmonary edema in the Himalaya: a review of 56 cases presenting at Pheriche medical aid post (4240 m). Wilderness Environ Med. 2013 ; 24 (1). 32-36
32. Chow T, Browne V, Heileson HL, Wallace D, Anholm J, Green SM. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial. Arch Intern Med. 2005 ; 165 (3). 296-301
33. Rexhaj E, Garcin S, Rimoldi SF, et al. Reproducibility of acute mountain sickness in children and adults: a prospective study. Pediatrics. 2011 ; 127 (6). e1445 - e1448
34. Hackett PH, Roach RC. High altitude cerebral edema. High Alt Med Biol. 2004 ; 5 (2). 136-146
35. Schoene RB. Unraveling the mechanism of high altitude pulmonary edema. High Alt Med Biol. 2004 ; 5 (2). 125-135
36. Paralikar SJ. High altitude pulmonary edema-clinical features, pathophysiology, prevention and treatment. Indian J Occup Environ Med. 2012 ; 16 (2). 59-62
37. Busch T, Bartsch P, Pappert D, et al. Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am J Respir Crit Care Med. 2001 ; 163 (2). 368-373
38. Whayne TF, Severinghaus JW. Experimental hypoxic pulmonary edema in the rat. J Appl Physiol. 1968 ; 25 (6). 729-732
39. Swenson ER, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. JAMA. 2002 ; 287 (17). 2228-2235
40. Hanaoka M, Kubo K, Yamazaki Y, et al. Association of high-altitude pulmonary edema with the major histocompatibility complex. Circulation. 1998 ; 97 (12). 1124-1128
41. Hultgren HN, Grover RF, Hartley LH. Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation. 1971 ; 44 (5). 759-770
42. Fasules JW, Wiggins JW, Wolfe RR. Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high-altitude pulmonary edema. Circulation. 1985 ; 72 (5). 957-962
43. Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med. 2002 ; 346 (21). 1631-1636
44. Maggiorini M. Prevention and treatment of high-altitude pulmonary edema. Prog Cardiovasc Dis. 2010 ; 52 (6). 500-506
45. Luo Y, Chen Y, Zhang Y, Zhou Q, Gao Y. Association of endothelial nitric oxide synthase (eNOS) G894T polymorphism with high altitude pulmonary edema susceptibility: a meta-analysis. Wilderness Environ Med. 2012 ; 23 (3). 270-274
46. MacInnis MJ, Koehle MS, Rupert JL. Evidence for a genetic basis for altitude illness: 2010 update. High Alt Med Biol. 2010 ; 11 (4). 349-368
47. Wang QQ, Yu L, Huang GR, et al. Polymorphisms of Angiotensin converting enzyme and nitric oxide synthase 3 genes as risk factors of high-altitude pulmonary edema: a case-control study and meta-analysis. Tohoku J Exp Med. 2013 ; 229 (4). 255-266
48. Berghold F. Diagnosis and therapy of acute altitude sickness [in German]. Wien Med Wochenschr. 2000 ; 150 (8-9). 169-174
49. Lipman GS, Kanaan NC, Holck PS, Constance BB, Gertsch JH. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med. 2012 ; 59 (6). 484-490
50. Kleinsasser A, Pircher I, Treml B, et al. Recombinant angiotensin-converting enzyme 2 suppresses pulmonary vasoconstriction in acute hypoxia. Wilderness Environ Med. 2012 ; 23 (1). 24-30
51. Merino CF. Studies on blood formation and destruction in the polycythemia of high altitude. Blood. 1950 ; 5 (1). 1-31
52. Penaloza D, Arias-Stella J. The heart and pulmonary circulation at high altitudes: healthy highlanders and chronic mountain sickness. Circulation. 2007 ; 115 (9). 1132-1146
53. Penaloza D, Sime F. Chronic cor pulmonale due to loss of altitude acclimatization (chronic mountain sickness). Am J Med. 1971 ; 50 (6). 728-743
54. Leon-Velarde F, Mejia O. Gene expression in chronic high altitude diseases. High Alt Med Biol. 2008 ; 9 (2). 130-139
55. Leon-Velarde F, Maggiorini M, Reeves JT, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005 ; 6 (2). 147-157
56. Muhm JM, Rock PB, McMullin DL, et al. Effect of aircraft-cabin altitude on passenger discomfort. N Engl J Med. 2007 ; 357 (1). 18-27
57. Gautret P, Gaudart J, Leder K, et al. Travel-associated illness in older adults (>60 y). J Travel Med. 2012 ; 19 (3). 169-177
58. Wilson MH, Edsell ME, Davagnanam I, et al. Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia - an ultrasound and MRI study. J Cereb Blood Flow Metab. 2011 ; 31 (10). 2019-2029
59. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA. 1998 ; 280 (22). 1920-1925
60. Pichler Hefti J, Risch L, Hefti U, et al. Changes of coagulation parameters during high altitude expedition. Swiss Med Wkly. 2010 ; 140 (7-8). 111-117
61. Allemann Y, Hutter D, Lipp E, et al. Patent foramen ovale and high-altitude pulmonary edema. JAMA. 2006 ; 296 (24). 2954-2958
62. Luks AM, Stout K, Swenson ER. Evaluating the safety of high-altitude travel in patients with adult congenital heart disease. Congenit Heart Dis. 2010 ; 5 (3). 220-232
63. Edelman NH, Lahiri S, Braudo L, Cherniack NS, Fishman AP. The blunted ventilatory response to hypoxia in cyanotic congenital heart disease. N Engl J Med. 1970 ; 282 (8). 405-411
64. Sorensen SC, Severinghaus JW. Respiratory insensitivity to acute hypoxia persisting after correction of tetralogy of Fallot. J Appl Physiol. 1968 ; 25 (3). 221-223
65. Hutchison SJ, Litch JA. Acute myocardial infarction at high altitude. JAMA. 1997 ; 278 (20). 1661-1662
66. Levine BD, Zuckerman JH, deFilippi CR. Effect of high-altitude exposure in the elderly: the Tenth Mountain Division study. Circulation. 1997 ; 96 (4). 1224-1232
67. Burtscher M, Ponchia A. The risk of cardiovascular events during leisure time activities at altitude. Prog Cardiovasc Dis. 2010 ; 52 (6). 507-511
68. West JB. Limiting factors for exercise at extreme altitudes. Clin Physiol. 1990 ; 10 (3). 265-272
69. de Mol P, de Vries ST, de Koning EJ, Gans RO, Tack CJ, Bilo HJ. Increased insulin requirements during exercise at very high altitude in type 1 diabetes. Diabetes Care. 2011 ; 34 (3). 591-595
70. de Paula P, Niebauer J. Effects of high altitude training on exercise capacity: fact or myth. Sleep Breath. 2012 ; 16 (1). 233-239
71. Fulco CS, Rock PB, Cymerman A. Improving athletic performance: is altitude residence or altitude training helpful?. Aviat Space Environ Med. 2000 ; 71 (2). 162-171
72. Ri-Li G, Chase PJ, Witkowski S, et al. Obesity: associations with acute mountain sickness. Ann Intern Med. 2003 ; 139 (4). 253-257
73. Sartori C, Allemann Y, Trueb L, Delabays A, Nicod P, Scherrer U. Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet. 1999 ; 353 (9171). 2205-2207
74. Arestegui AH, Fuquay R, Sirota J, et al. High altitude renal syndrome (HARS). J Am Soc Nephrol. 2011 ; 22 (11). 1963-1968
75. Hurtado A, Escudero E, Pando J, Sharma S, Johnson RJ. Cardiovascular and renal effects of chronic exposure to high altitude. Nephrol Dial Transplant. 2012 ; 27 (suppl 4). iv11 - iv16
76. Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB, Subramanyam CS. Acute mountain sickness. N Engl J Med. 1969 ; 280 (4). 175-184
77. Frayser R, Houston CS, Bryan AC, Rennie ID, Gray G. Retinal hemorrhage at high altitude. N Engl J Med. 1970 ; 282 (21). 1183-1184
78. McFadden DM, Houston CS, Sutton JR, Powles AC, Gray GW, Roberts RS. High-altitude retinopathy. JAMA. 1981 ; 245 (6). 581-586
79. MacCormick IJ, Somner J, Morris DS, et al. Retinal vessel tortuosity in response to hypobaric hypoxia. High Alt Med Biol. 2012 ; 13 (4). 263-268
80. Bloch KE, Latshang TD, Turk AJ, et al. Nocturnal periodic breathing during acclimatization at very high altitude at Mount Muztagh Ata (7,546 m). Am J Respir Crit Care Med. 2010 ; 182 (4). 562-568
81. Latshang TD, Nussbaumer-Ochsner Y, Henn RM, et al. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial. JAMA. 2012 ; 308 (22). 2390-2398
82. Marticorena E, Marticorena JM, Contreras Gonzalez AC, et al. Rehabilitacion cardiaca con altura simulada (camara hipobarica) en coronarios con infarto de miocardio y by-pass. Rev Peruana de Cardiologia. 1995 ; 21: 7-15
83. Sherpa LY, Deji Stigum H, et al. Lipid profile and its association with risk factors for coronary heart disease in the highlanders of Lhasa, Tibet. High Alt Med Biol. 2011 ; 12 (1). 57-63
84. Mohanna S, Baracco R, Seclen S. Lipid profile, waist circumference, and body mass index in a high altitude population. High Alt Med Biol. 2006 ; 7 (3). 245-255
85. Hirschler V, Maccallini G, Aranda C, Molinari C. Dyslipidemia without obesity in indigenous Argentinean children living at high altitude. J Pediatr. 2012 ; 161 (4). 646-651
86. Hartmann G, Tschop M, Fischer R, et al. High altitude increases circulating interleukin-6, interleukin-1 receptor antagonist and C-reactive protein. Cytokine. 2000 ; 12 (3). 246-252
87. Hagobian TA, Jacobs KA, Subudhi AW, et al. Cytokine responses at high altitude: effects of exercise and antioxidants at 4300 m. Med Sci Sports Exerc. 2006 ; 38 (2). 276-285
88. Vij AG. Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels. Platelets. 2009 ; 20 (6). 421-427
89. Smith JD, Cianflone K, Martin J, Poirier P, Broderick TL, Noel M. Plasma adipokine and hormone changes in mountaineers on ascent to 5300 meters. Wilderness Environ Med. 2011 ; 22 (2). 107-114
90. Chen MT, Lee WC, Chen SC, et al. Effect of a prolonged altitude expedition on glucose tolerance and abdominal fatness. Res Q Exerc Sport. 2010 ; 81 (4). 472-477
91. Scherrer U, Allemann Y, Jayet PY, Rexhaj E, Sartori C. High altitude, a natural research laboratory for the study of cardiovascular physiology and pathophysiology. Prog Cardiovasc Dis. 2010 ; 52 (6). 451-455
92. Rupert JL, Hochachka PW. The evidence for hereditary factors contributing to high altitude adaptation in Andean natives: a review. High Alt Med Biol. 2001 ; 2 (2). 235-256